Cargando…
Pharmacological Management of Atypical Hemolytic Uremic Syndrome in Pediatric Patients: Current and Future
Atypical hemolytic uremic syndrome is a thrombotic microangiopathy characterized by hemolysis, thrombocytopenia, and acute kidney injury, usually caused by alternative complement system overactivation due to pathogenic genetic variants or antibodies to components or regulatory factors in this pathwa...
Autores principales: | Gurevich, Evgenia, Landau, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839393/ https://www.ncbi.nlm.nih.gov/pubmed/36637720 http://dx.doi.org/10.1007/s40272-022-00555-6 |
Ejemplares similares
-
Pediatric Atypical Hemolytic Uremic Syndrome Advances
por: Raina, Rupesh, et al.
Publicado: (2021) -
Atypical hemolytic uremic syndrome
por: Loirat, Chantal, et al.
Publicado: (2011) -
Pathogenesis of Atypical Hemolytic Uremic Syndrome
por: Yoshida, Yoko, et al.
Publicado: (2019) -
Atypical Hemolytic Uremic Syndrome
por: Kavanagh, David, et al.
Publicado: (2013) -
Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome
por: Lee, Hajeong, et al.
Publicado: (2020)